Immunotherapeutic HCW9218 augments anti-tumor activity of chemotherapy via NK cell-mediated reduction of therapy-induced senescent cells-Reference-Cited by-同舟云学术

Immunotherapeutic HCW9218 augments anti-tumor activity of chemotherapy via NK cell-mediated reduction of therapy-induced senescent cells

Published:2022-03 Issue:3 Volume:30 Page:1171-1187
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Chaturvedi Pallavi,George Varghese,Shrestha Niraj,Wang Meng,Dee Michael J.,Zhu Xiaoyun,Liu Bai,Egan Jack,D'Eramo Francesca,Spanoudis Catherine,Gallo Victor,Echeverri Christian,You Lijing,Kong Lin,Fang Byron,Jeng Emily K.,Rhode Peter R.,Wong Hing C.

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference55 articles.

1. Therapy-induced senescence in cancer;Ewald;J. Natl. Cancer Inst.,2010

2. DNA damage is able to induce senescence in tumor cells in vitro and in vivo;te Poele;Cancer Res.,2002

3. Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers;Roberson;Cancer Res.,2005

4. Morphological and functional characteristic of senescent cancer cells;Sikora;Curr. Drug Targets,2016

5. Mechanisms and functions of cellular senescence;Herranz;J. Clin. Invest.,2018

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomodulation: A new approach to cancer cachexia, potentially suitable for aging;Molecular Aspects of Medicine;2024-12

2. Novel insights into immune cells modulation of tumor resistance;Critical Reviews in Oncology/Hematology;2024-10

3. Stimulating the Antitumor Immune Response Using Immunocytokines: A Preclinical and Clinical Overview;Pharmaceutics;2024-07-24

4. Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment;Cancer Communications;2024-07-12

5. Impact and potential value of immunosenescence on solid gastrointestinal tumors;Frontiers in Immunology;2024-06-28